25C-NBOMe
4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
1Provenance card
the boundary, as counts
Sources
2722 with DOI
3 strong · 19 moderate · 5 weak
Compilations
12026-04-28T06:37:16.441Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
31last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:29:07.697Z
notice · info card · emergency
Searches
171 with no results
queries and counts on the build
Claims checked
8855 supported
55 supported · 33 not
Correspondence
0received
consent field ships in Phase 4
Edges
268
derivations recorded for this entity
Complete over 27 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/25c-nbome/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcIn vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
- 2026-09-24srcPharmacology and Toxicology of N-Benzylphenethylamine (NBOMe) Hallucinogens
- 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
- 2026-09-24src25I-NBOMe: clinical case with unique confirmatory testing
- 2026-09-24srcIdentification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays
- 2026-09-24srcA fatal poisoning involving 25C-NBOMe.
- 2026-09-24srcMetabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.
- 2026-09-24srcReceptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
- 2026-09-24srcComparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats
- 2026-09-24srcToxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.
- 2026-09-24srcNew psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-a-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations.
- 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-24srcN-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues
- 2026-09-24srcIdentification of 5-HT2A receptor signaling pathways associated with psychedelic potential
- 2026-09-24srcAnalysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl)Methyl]Ethanamine Derivatives on Blotter Paper.
- 2026-09-24srcMetabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
- 2026-09-24src25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug
- 2026-09-24srcRadiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET.
- 2026-09-24srcTwo cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
- 2026-09-24srcCase series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
- 2026-09-24srcNBOMes-Highly Potent and Toxic Alternatives of LSD
- 2026-09-24srcAcute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation
- 2026-09-24srcLysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain
- 2026-09-24srcSchedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
- 2026-09-24srcNBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review
- 2026-09-24srcSchedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
- 2026-09-24src25C-NBOMe legal status: UK Class A, Canada Schedule III, Russia, Brazil, Israel, Sweden, US State scheduling
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-28revisionRevision 1
- 2026-04-28absenceSearched ClinicalTrials.gov for "25C-NBOMe" — no results
- 2026-04-28genGeneration — pipeline-v5pipeline-v5
- 2026-04-28rungeneration run
The same entries, as forms: six forms.